NZ185318A - Derivatives of 1-phenoxy-3-amino-2-propanol and pharmaceutical compositions - Google Patents

Derivatives of 1-phenoxy-3-amino-2-propanol and pharmaceutical compositions

Info

Publication number
NZ185318A
NZ185318A NZ185318A NZ18531877A NZ185318A NZ 185318 A NZ185318 A NZ 185318A NZ 185318 A NZ185318 A NZ 185318A NZ 18531877 A NZ18531877 A NZ 18531877A NZ 185318 A NZ185318 A NZ 185318A
Authority
NZ
New Zealand
Prior art keywords
phenoxy
propanol
derivatives
amino
pharmaceutical compositions
Prior art date
Application number
NZ185318A
Other languages
English (en)
Inventor
B Lundgren
E Carlsson
G Samuelsson
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NZ185318A publication Critical patent/NZ185318A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Epoxy Compounds (AREA)
NZ185318A 1976-10-07 1977-10-03 Derivatives of 1-phenoxy-3-amino-2-propanol and pharmaceutical compositions NZ185318A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7611125A SE416545B (sv) 1976-10-07 1976-10-07 Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat

Publications (1)

Publication Number Publication Date
NZ185318A true NZ185318A (en) 1980-02-21

Family

ID=20329066

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ185318A NZ185318A (en) 1976-10-07 1977-10-03 Derivatives of 1-phenoxy-3-amino-2-propanol and pharmaceutical compositions

Country Status (22)

Country Link
JP (1) JPS5346928A (da)
AT (1) AT351509B (da)
AU (1) AU516727B2 (da)
BE (1) BE859474A (da)
CA (1) CA1093096A (da)
CH (1) CH636337A5 (da)
CS (5) CS208732B2 (da)
DD (1) DD132195A5 (da)
DE (1) DE2743493A1 (da)
DK (1) DK145375C (da)
FI (1) FI772936A (da)
FR (1) FR2367054A1 (da)
GB (1) GB1589838A (da)
HU (1) HU177638B (da)
IE (1) IE45938B1 (da)
LU (1) LU78263A1 (da)
NL (1) NL7710941A (da)
NO (1) NO145436C (da)
NZ (1) NZ185318A (da)
SE (1) SE416545B (da)
SU (3) SU735166A3 (da)
ZA (1) ZA775603B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
JPH0627370B2 (ja) * 1985-08-23 1994-04-13 日本エステル株式会社 ポリエステル異形断面太細糸
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE590054A (fr) * 1959-04-22 1960-10-24 Pfizer Alkylamines et leur préparation.
GB1264128A (da) * 1968-06-29 1972-02-16
GB1433920A (en) * 1973-10-01 1976-04-28 Ici Ltd Alkanolamine derivatives

Also Published As

Publication number Publication date
IE45938L (en) 1978-04-07
NO145436B (no) 1981-12-14
NL7710941A (nl) 1978-04-11
DK145375B (da) 1982-11-08
DE2743493A1 (de) 1978-04-13
LU78263A1 (da) 1978-06-09
CH636337A5 (en) 1983-05-31
SE416545B (sv) 1981-01-19
SU784760A3 (ru) 1980-11-30
AU516727B2 (en) 1981-06-18
ZA775603B (en) 1978-06-28
CS208732B2 (en) 1981-09-15
DK443177A (da) 1978-04-08
CS208731B2 (en) 1981-09-15
JPS5346928A (en) 1978-04-27
NO145436C (no) 1982-03-24
DD132195A5 (de) 1978-09-06
CA1093096A (en) 1981-01-06
DK145375C (da) 1983-04-11
CS208730B2 (en) 1981-09-15
SU735166A3 (ru) 1980-05-15
FR2367054A1 (fr) 1978-05-05
AU2930077A (en) 1979-04-12
AT351509B (de) 1979-07-25
SE7611125L (sv) 1978-04-08
ATA702177A (de) 1979-01-15
FR2367054B1 (da) 1981-11-06
NO773406L (no) 1978-04-10
BE859474A (fr) 1978-04-07
HU177638B (en) 1981-11-28
SU959623A3 (ru) 1982-09-15
CS208734B2 (en) 1981-09-15
GB1589838A (en) 1981-05-20
FI772936A (fi) 1978-04-08
IE45938B1 (en) 1983-01-12
CS208733B2 (en) 1981-09-15

Similar Documents

Publication Publication Date Title
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
NZ185105A (en) Thiazolidine derivatives and pharmaceutical compositions
NZ187235A (en) Aminoalkylbenzene derivatives and pharmaceutical compositions
PH15711A (en) Acylamino derivatives and pharmaceutical compositions thereof
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
IL51812A0 (en) New isothiazolopyridine derivatives their preparation and pharmaceutical compositions containing them
NZ186119A (en) 7-alkoxycarbonyl-6-alkyl/halo-17-hydoxy-3-oxo-17 -pregn-4-ene-21-carboxylic acid derivatives and pharmaceutical compositions
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
PH13392A (en) Thiourea derivatives and pharmaceutical compositions containing them
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
NZ184408A (en) 16-s-acyl derivatives of 16-deacetoxy-fusidic acid and pharmaceutical compositions
IL51955A0 (en) Novel thiazole derivatives their preparation and pharmaceutical compositions containing them
NZ187085A (en) 3-pyridazione derivatives and pharmaceutical compositions
NZ187571A (en) N-glucofuranosid-6-yl-n-nitroso-urea derivatives and pharmaceutical compositions
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions
NZ186059A (en) 3-sulphamoyl-5-pyrrolylal-kylbenzoic acid derivatives and pharmaceutical compositions
NZ185267A (en) Derivatives of 1-amino-2hydroxy-3-heterocycloxy-propanes, and pharmaceutical compositions containing them
NZ181401A (en) 2-benzopyranone derivatives and pharmaceutical compositions
IL53642A0 (en) New indoloquinolizine derivatives their preparation and pharmaceutical compositions containing them
NZ187195A (en) Benzenesulphonyl-urea derivatives and pharmaceutical compositions
NZ185295A (en) 9-chloroprednisolone derivatives and pharmaceutical compositions